Assembly Biosciences, Inc. Operating Lease Right-of-Use Assets
Assembly Biosciences, Inc. (ASMB) had Operating Lease Right-of-Use Assets of $2.23 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $2.23M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $2.37M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $2.51M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $2.64M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $2.23M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.37M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.51M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $2.64M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $2.78M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $2.93M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.07M 10-K · filed 2026-03-19 |
| 2024-09-30 | $1.42M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.73M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.04M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.34M 10-K · filed 2025-03-20 |
| 2023-09-30 | $844.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.62M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.42M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.19M 10-K · filed 2024-03-28 |
| 2022-09-30 | $3.96M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.71M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $5.30M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $6.04M 10-K · filed 2023-03-22 |
| 2021-09-30 | $6.77M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.49M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $8.10M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $9.13M 10-K · filed 2022-03-11 |
| 2020-09-30 | $10.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $10.78M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $11.48M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $11.97M 10-K · filed 2021-02-25 |
| 2019-09-30 | $12.78M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $12.67M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $13.06M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $13.80M 10-K · filed 2020-03-04 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |